Saturday 17 October 2026 Export NHC’s income statement to Excel — free account

National HealthCare Corporation

National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024. In the quarter to June 2026, revenue grew 8.83%, EPS grew 68.6%, free cash flow fell 41.6% and total debt fell 94.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

242.82 2.71 −1.10%

Follow NHC

Alert me

Market cap: $3.9B
P/E: 26.9×
Fwd P/E: 8.4×
Dividend yield: 1.08%
F-score: 7/9
Altman Z: 5.02
Beneish M: −2.57
Dividend safety: 74/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.17

Total sells 10.55

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	1	—	—	—	—
Sell	3	1	—	—	—	—	2	2	—	3	2	—

Insider Ownership 18.55%

Capital & Financial Ratios $m

Market Cap 3,850.00

Revenue 1,559.02

Net Income 142.84

Free Cash Flow 146.53

Net Debt (265.88)

Current Ratio 1.86

Debt/Equity 0.00

P/E ratio 26.92

Fwd P/E 8.40

P/S ratio 2.43

P/B ratio 3.36

Past 5Y EPS Growth 23.04%

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth 41.32%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 80.32%

10-year low 10-year high

P/S against its own 10 years 99.96%

10-year low 10-year high

P/B against its own 10 years 99.96%

10-year low 10-year high

EV/Sales against its own 10 years 99.96%

10-year low 10-year high

EV/FCF against its own 10 years 79.61%

10-year low 10-year high

Dividends

Payout Ratio 0.29

Annual Dividend Rate 2.62

Annual Dividend Yield 1.08%

	total	individual payouts
2026	0.40	0.64 0.67 0.67
2025	0.43	0.61 0.64 0.64 0.64
2024	2.42	0.59 0.61 0.61 0.61
2023	2.91	0.57 0.59 0.59 0.59 0.57
2022	2.26	0.55 0.57 0.57 0.57
2021	2.11	0.52 0.52 0.52 0.55
2020	2.08	0.52 0.52 0.52 0.52
2019	2.06	0.50 0.52 0.52 0.52
2018	1.98	0.48 0.50 0.50 0.50
2017	1.89	0.45 0.48 0.48 0.48
2016	1.75	0.40 0.45 0.45 0.45

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	281	270	309	266
Receivables	109	135	139	138
Inventory	7	9	8	9
Other	—	—	—	—
	406	424	462	440

	2023	2024	2025	Q'26
Payables	19	25	23	22
ST’ Debt	—	8	8	—
Other	23	21	26	31
	214	235	254	236

Compound Annual Growth %

	10y	5y	3y
Sales	5.29%	8.10%	11.81%
Cash Flow	8.30%	(1.86%)	176.64%
Earnings	9.99%	23.44%	74.87%
Book Value	5.47%	6.12%	6.98%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	382	408	—	—	—
’25	374	375	383	387	1,518
’24	297	301	340	369	1,307
’23	270	283	288	301	1,142
’22	279	271	271	265	1,086
’21	251	263	277	283	1,074
’20	256	262	251	260	1,028

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	63	43	—	—	—
’25	39	63	66	17	185
’24	10	51	34	13	107
’23	14	39	32	26	111
’22	(27)	26	(2)	12	9
’21	13	28	7	16	62
’20	8	147	29	19	203

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	53	31	—	—	—
’25	33	53	56	6	149
’24	4	43	29	7	82
’23	7	33	26	17	83
’22	(36)	21	(8)	6	(17)
’21	8	19	(6)	2	23
’20	1	134	31	15	181

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	2.27	2.54	—	—	—
’25	2.07	1.52	2.50	1.58	7.67
’24	1.69	1.73	2.73	0.39	6.53
’23	0.76	1.06	0.68	1.83	4.34
’22	0.99	0.21	(0.16)	0.41	1.45
’21	1.38	6.80	(0.22)	1.02	8.99
’20	(1.76)	1.84	0.84	1.79	2.72

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	57.16	57.73	57.00	70.89	55.88	62.57	57.61	51.56	87.03	89.14	Analyst estimates 2026–2028 Powerpack
	High	78.99	77.01	84.90	89.55	88.35	79.73	75.35	98.17	138.49	144.53
People
People	Employees	14,450	14,850	14,891	14,881	13,432	12,965	12,355	13,123	14,962	15,278
	Revenue/emp, $m	0.06	0.06	0.07	0.07	0.08	0.08	0.09	0.09	0.09	0.10
Income, $m
Income, $m	Revenue	924	964	980	996	1,028	1,074	1,086	1,142	1,307	1,518
	Gross margin, %	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
	EBT	80	75	75	88	52	150	27	89	136	162
	EBT margin, %	8.68	7.73	7.64	8.83	5.10	13.97	2.51	7.77	10.43	10.70
	Net income	51	56	59	68	42	139	20	65	102	123
	Depreciation	39	43	42	42	42	41	46	42	42	45
Per share, $
Per share, $	Revenue	61.02	63.46	64.39	65.25	67.18	70.00	70.46	74.56	84.93	98.10
	Earnings	3.34	3.70	3.87	4.47	2.74	9.03	1.46	4.36	6.62	7.76
	Cash flow	6.00	6.22	6.47	6.56	13.28	4.07	0.57	7.26	6.97	11.96
	Capex	(4.14)	(2.13)	(1.96)	(1.73)	(1.43)	(2.57)	(1.69)	(1.82)	(1.66)	(2.36)
	Free cash flow	1.87	4.09	4.51	4.83	11.85	1.50	(1.12)	5.44	5.31	9.61
	Book value	44.24	46.31	48.24	51.02	52.15	59.19	56.94	59.47	63.87	69.45
	Shares, m	15	15	15	15	15	15	15	15	15	15
Valuation, ×
Valuation, ×	P/E	22.52	16.74	20.22	19.38	24.33	7.52	41.15	21.39	16.25	17.69
	P/S	1.24	0.98	1.22	1.32	0.99	0.97	0.85	1.25	1.27	1.40
	P/B	1.71	1.34	1.63	1.69	1.27	1.15	1.05	1.57	1.68	1.97
	EV/Sales	1.06	0.77	1.03	1.12	0.68	0.71	0.66	1.09	1.16	1.24
	EV/FCF	34.70	11.94	14.64	15.09	3.87	33.33	(41.55)	14.97	18.61	12.68
Cash, $m
Cash, $m	Operating cash flow	91	94	98	100	203	62	9	111	107	185
	Capex	(63)	(32)	(30)	(26)	(22)	(39)	(26)	(28)	(25)	(36)
	Free cash flow	28	62	69	74	181	23	(17)	83	82	149
Balance, $m
Balance, $m	Working capital	140	174	164	146	176	163	156	192	190	208
	Total debt	30	27	23	25	41	38	35	—	137	8
	Net debt	(160)	(199)	(189)	(207)	(314)	(276)	(201)	(281)	(133)	(302)
	Shareholders’ equity	670	703	734	779	798	908	878	910	983	1,075
Returns, %
Returns, %	ROA	4.74	5.15	5.42	5.76	3.16	10.02	1.68	5.17	7.19	7.87
	ROIC	7.92	7.30	6.96	5.70	6.39	5.12	3.00	5.70	6.61	10.38
	ROE	7.77	8.19	8.20	9.01	5.31	16.24	2.51	7.47	10.77	11.67

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
LFST LifeStance Health Group, Inc.	$4.7B	88.3×	58.5×	+26.08% (above 0%: growing)	n/m	+55.22% (above 0%: growing)	35.15%	7.04%	Compare
OPCH Option Care Health, Inc.	$4.7B	23.5×	14.1×	+1.86% (above 0%: growing)	+12.90% (above 0%: growing)	+112.36% (above 0%: growing)	18.53%	5.90%	Compare
NHC National HealthCare Corporation	$3.9B	26.9×	8.4×	+8.83% (above 0%: growing)	+68.63% (above 0%: growing)	−41.57% (below 0%: shrinking)	100.00%	11.99%
ACHC Acadia Healthcare Company, Inc.	$2.9B	— (loss-making)	21.1×	−0.39% (below 0%: shrinking)	−63.64% (below 0%: shrinking)	+856.54% (above 0%: growing)	100.00%	10.14%	Compare
AVAH Aveanna Healthcare Holdings Inc.	$2.8B	9.5×	10.4×	+13.73% (above 0%: growing)	+46.15% (above 0%: growing)	+57.89% (above 0%: growing)	32.59%	11.93%	Compare
GRDN Guardian Pharmacy Services, Inc.	$2.5B	37.5×	39.5×	+2.16% (above 0%: growing)	+133.33% (above 0%: growing)	+60.83% (above 0%: growing)	22.75%	5.87%	Compare
BKD Brookdale Senior Living Inc.	$2.4B	— (loss-making)	— (loss-making)	−11.61% (below 0%: shrinking)	n/m	+533.14% (above 0%: growing)	29.94%	11.86%	Compare
MD Pediatrix Medical Group, Inc.	$2.3B	13.1×	11.3×	+4.04% (above 0%: growing)	+6.52% (above 0%: growing)	−6.56% (below 0%: shrinking)	27.16%	11.67%	Compare
Median of peers	$2.8B	24.2×	17.0×	+3.10%	+29.31%	+76.23%	30.82%	10.91%

All 55 Medical Care Facilities stocks →

National HealthCare Corporation (NHC) key facts

Strength: National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024.
Strength: Net income was $122.6 million, or $7.76 per share (basic), a net margin of 7.91%.
National HealthCare Corporation (NHC) is a Medical Care Facilities company in the Healthcare sector, listed on NYSE American.
As of October 16, 2026, NHC traded at $242.82, a market capitalization of $3.9 billion.
At that price the stock trades at 26.9× trailing-twelve-month earnings and 2.4× sales; its P/E is higher than 80% of its own readings over the past ten years.
National HealthCare Corporation pays an annual dividend of $2.62 per share, a yield of 1.08%, with a payout ratio of 29.5%.
Return on equity was 11.7% and debt-to-equity 0.00.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 5.02 (safe zone) for fiscal 2025.